Skip to main navigation Skip to search Skip to main content

Exploration and understanding of endocrine mono- and combination therapy resistance in hormone receptor positive/HER2 negative breast cancer

  • Zhangzan Huang

Research output: Types of ThesisDoctoral ThesisInternal

22 Downloads (Pure)

Abstract

In this thesis, we extended the investigation of endocrine therapy resistance in HR+/HER2- breast cancer, aiming to elucidate cross-resistance mechanisms and identify potential response biomarkers. The research in this thesis is structured as follows, from functional and discovery research in cellular model systems to translational research in clinical specimen.
Original languageEnglish
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • Martens, John, Supervisor
  • Jansen, Maurice P.H.M., Co-supervisor
Award date23 Apr 2026
Place of PublicationRotterdam
Print ISBNs978-90-9042-124-7
Publication statusPublished - 23 Apr 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Exploration and understanding of endocrine mono- and combination therapy resistance in hormone receptor positive/HER2 negative breast cancer'. Together they form a unique fingerprint.

Cite this